Skip to content
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact

Month: March 2025

GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk – Drugs.com MedNews

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 …

Trouble sleeping? The culprit may be something you ate – American Heart Association

Among women, it altered levels of GLP-1, reducing satiety, meaning women felt less full after eating. So what foods should people eat if they want …

Hims & Hers Stock Dip and What It Means for Telehealth and Clinicians

… semaglutide shortage had been resolved. Semaglutide is the active ingredient in weight loss meds like Ozempic and Wegovy, and compounding is legal …

AbbVie gets into obesity with $350M deal for once-weekly shot | BioPharma Dive

If successful, these drugs could be used as alternatives to or in combination with marketed drugs like Novo’s Wegovy and Lilly’s Zepbound to increase …

How to trick the body’s metabolism: Mouse study reveals new path for weight-loss and diabetes treatments

Many people who have tried to lose weight by cutting calories are familiar with this frustrating reality: At some point, the body stops shedding pounds. It senses the reduced calorie intake and responds by slowing down metabolism, causing it to burn fewer calories than before the diet.

Semaglutide: A Promising Treatment for Alcohol Use Disorder – INSCMagazine

Semaglutide, a GLP-1 receptor agonist initially approved for type 2 diabetes and later for weight management, is now showing potential in treating …

Novo Nordisk Launches National “My Ozempic® Era” Campaign Celebrating Stories of …

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used: along with diet and exercise to improve blood …

Low-carb, low-fibre diets could raise risks of colon cancer – Toronto Star

Numerous studies have shown that a diet high in sugar and fat — a so-called “Western-style diet” — is linked to colorectal cancer, as well as obesity …

Targeted drug offers hope for safe, effective senolytic treatment for liver disease, cancer

… obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or …

Tesla, Broadcom, Strategy, Coinbase, Robinhood: Stocks to watch today – Quartz

Eli Lilly wants to replace Zepbound with an even stronger weight loss drug. Nvidia’s record earnings reveal just 3 customers make up 30% of revenue.

← Previous
Next →
© Copyright 2025 GenWeb of Texas